Literature DB >> 29929904

Diffusional kurtosis imaging in assessing renal function and pathology of IgA nephropathy: a preliminary clinical study.

Y Liu1, G-M-Y Zhang2, X Peng1, Y Wen1, W Ye1, K Zheng1, X Li1, H Sun3, L Chen4.   

Abstract

AIM: To evaluate renal fibrosis in immunoglobulin A nephropathy (IgAN) using diffusion kurtosis imaging (DKI).
MATERIALS AND METHODS: Twenty patients with biopsy-proven IgAN were enrolled. DKI was performed on a clinical 3 T magnetic resonance imaging (MRI) system, and region-of-interest measurements were conducted to determine mean kurtosis (K), mean diffusivity (D), and apparent diffusion coefficient (ADC) of the kidney cortex. Renal biopsy specimens were scored based on the severity of renal fibrosis. The associations between the DKI data and clinicopathological parameters were investigated.
RESULTS: Both the K and ADC were not only well correlated with the estimated glomerular filtration rate, but also significantly associated with the pathological scores of fibrosis, including the glomerular sclerosis index (K: r=0.759, p<0.001; ADC: r=-0.636, p=0.003) and the percentage of tubular atrophy and interstitial fibrosis (K: r=0.767, p<0.001; ADC: r=-0.702, p=0.001). Further receiver operating characteristic analysis showed that K demonstrated better diagnostic performance in discriminating severe glomerulosclerosis (area under curve [AUC] 0.970, sensitivity 81.8%, specificity 100%), and ADC displayed better capabilities in identifying severe tubular atrophy/interstitial fibrosis (AUC 0.976, sensitivity 100%, specificity 92.9%).
CONCLUSION: This DKI method can be used to detect renal fibrosis in IgAN in a non-invasive manner and may provide additional information for characterisation and surveillance.
Copyright © 2018 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29929904     DOI: 10.1016/j.crad.2018.05.012

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  7 in total

1.  Noninvasive assessment of renal function and fibrosis in CKD patients using histogram analysis based on diffusion kurtosis imaging.

Authors:  Guanjie Yuan; Weinuo Qu; Shichao Li; Ping Liang; Kangwen He; Anqin Li; Jiali Li; Daoyu Hu; Chuou Xu; Zhen Li
Journal:  Jpn J Radiol       Date:  2022-10-18       Impact factor: 2.701

Review 2.  Multiparametric Functional Magnetic Resonance Imaging for Evaluating Renal Allograft Injury.

Authors:  Yuan Meng Yu; Qian Qian Ni; Zhen Jane Wang; Meng Lin Chen; Long Jiang Zhang
Journal:  Korean J Radiol       Date:  2019-06       Impact factor: 3.500

3.  Assessment of chronic allograft injury in renal transplantation using diffusional kurtosis imaging.

Authors:  Xin Zheng; Min Li; Pan Wang; Xiangnan Li; Qiang Zhang; Song Zeng; Tao Jiang; Xiaopeng Hu
Journal:  BMC Med Imaging       Date:  2021-04-07       Impact factor: 1.930

4.  Noninvasive assessment of clinical and pathological characteristics of patients with IgA nephropathy by diffusion kurtosis imaging.

Authors:  Ping Liang; Shichao Li; Guanjie Yuan; Kangwen He; Anqin Li; Daoyu Hu; Zhen Li; Chuou Xu
Journal:  Insights Imaging       Date:  2022-01-29

5.  Renal functional and interstitial fibrotic assessment with non-Gaussian diffusion kurtosis imaging.

Authors:  Anqin Li; Guanjie Yuan; Yao Hu; Yaqi Shen; Xuemei Hu; Daoyu Hu; Zhen Li
Journal:  Insights Imaging       Date:  2022-04-08

6.  Iopromide and Iodixanol in the Development of Postoperative Contrast Nephropathy in Patients with Renal Insufficiency: A Meta-Analysis.

Authors:  Yiyu Feng; Guoping Qiu; Chengyun Xu; Zhibing Duan; Manting Wang; Lamei Wang; Wenjie Hu; Peifang Li; Hui Zhou
Journal:  J Healthc Eng       Date:  2022-04-05       Impact factor: 2.682

7.  Evaluation of contrast-induced acute kidney injury using IVIM and DKI MRI in a rat model of diabetic nephropathy.

Authors:  Hongyan Dai; Chun Zhao; Yuxin Xiong; Qian He; Wei Su; Jianbo Li; Ying Yang; Ruyun Lin; Shutian Xiang; Juwei Shao
Journal:  Insights Imaging       Date:  2022-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.